Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Chest|October 18, 2000
Alveolar hemorrhage in systemic lupus erythematosus: presentation and managementA S Santos-Ocampo, B F Mandell, B J Fessler
Laboratory Investigation; a Journal of Technical Methods and Pathology|August 1, 1988
Suppression of acute inflammation by 15 methyl prostaglandin E1G A Tate, B F Mandell, H R Schumacher, et al.
The American Journal of Pediatric Hematology/Oncology|February 1, 1993
Recombinant human GM-CSF treatment of neutropenia in glycogen storage disease-1bD Hurst, L Kilpatrick, J Becker, et al.
The Journal of Rheumatology|June 1, 1989
Suppression of acute and chronic inflammation by dietary gamma linolenic acidG Tate, B F Mandell, M Laposata, et al.
Arthritis and Rheumatism|December 1, 1988
Suppression of monosodium urate crystal-induced acute inflammation by diets enriched with gamma-linolenic acid and eicosapentaenoic acidG A Tate, B F Mandell, R A Karmali, et al.
The Biochemical Journal|October 15, 1978
Plasma clearance of glycoproteins with terminal mannose and N-acetylglucosamine by liver non-parenchymal cells. Studies with beta-glucuronidase, N-acetyl-beta-D-glucosaminidase, ribonuclease B and agalacto-orosomucoidP H Schlesinger, T W Doebber, B F Mandell, et al.
The Journal of Rheumatology|May 22, 2001
Standardizing assessment of adverse effects in rheumatology clinical trials. Status of OMERACT Toxicity Working Group March 2000: towards a common understanding of comparative toxicity/safety profiles for antirheumatic therapiesT G Woodworth, D E Furst, V Strand, et al.
Blood|May 1, 1991
Phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor following allogeneic bone marrow transplantationJ Nemunaitis, C D Buckner, F R Appelbaum, et al.
The Journal of Rheumatology|July 24, 1998
Clinical and immunologic effects of a PRIMATIZED anti-CD4 monoclonal antibody in active rheumatoid arthritis: results of a phase I, single dose, dose escalating trialD E Yocum, A M Solinger, J Tesser, et al.
Journal of Clinical Immunology|March 1, 1996
Relationships between antibodies against human soluble complement receptor 1 (hsCR1) from various speciesE V Ruggieri, P J Bugelski, J M Kaplan, et al.
Pageof 4